Market Tracker

07/27 5:16pm ET

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.2561
Delayed Data
As of 4:02pm ET
 +0.0011 / +0.43%
Today’s Change
0.24
Today|||52-Week Range
0.65
-29.45%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close0.26
Today’s open0.26
Day’s range0.25 - 0.26
Volume484,122
Average volume (3 months)567,685
Market cap$54.4M
Dividend yield--
Data as of 4:02pm ET, 07/27/2016

Growth & Valuation

Earnings growth (last year)+27.27%
Earnings growth (this year)-12.50%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.68

Competitors

 Today’s
change
Today’s
% change
IMMYImprimis Pharmaceuti...-0.06-1.48%
OCRXOcera Therapeutics I...-0.01-0.43%
CATBCatabasis Pharmaceut...+0.14+4.02%
NTECIntec Pharma Ltd0.000.00%
Data as of 3:59pm ET, 07/27/2016

Financials

Next reporting dateAugust 11, 2016
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$0.00
Annual profit (last year)-$14.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Peter David Suzdak
Chief Financial Officer, Secretary &
Senior VP
Tae Heum Jeong
Corporate headquarters
Rockville, Maryland

Forecasts